Skip to main content
. 2021 Jan 18;11:611504. doi: 10.3389/fneur.2020.611504

Table 1.

In-hospital workflow metrics in the periods before and during the With-COVID-19 pandemic in the National Cerebral and Cardiovascular Center.

Pre-COVID-19 period With-COVID-19 period P-value
December 2019 to March 2020 (N = 44) April 2020 to July 2020 (N = 49)
Age, year; median (IQR) 79 (65–86) 75 (65–86) 0.20
Female, n (%) 15 (34) 10 (20) 0.16
Premorbid mRS score, median (IQR) 0 (0–1) 0 (0–1) 0.55
Baseline NIHSS score, median (IQR) 11 (6–20) 10 (5–19) 0.56
Large artery atherosclerosis, n (%) 9 (20) 7 (14) 0.58
Cardioembolism, n (%) 23 (52) 26 (53) 1.00
Small vessel disease, (%) 1 (2) 0 (0) 0.47
Other cause, n (%) 9 (20) 11 (22) 1.00
Undetermined cause, n (%) 2 (5) 5 (10) 0.44
IVT only, n (%) 22 (50) 30 (61) 0.30
Bridging IVT with MT, n (%) 12 (27) 11 (22) 0.64
MT only, n (%) 10 (23) 8 (16) 0.60
Stroke onset to hospital arrival time, min, median (IQR) 71 (52–182) 109 (49–182) 0.54
Hospital arrival to brain imaging time, min, median (IQR) 25 (21–33) 30 (25–38) 0.03
Hospital arrival to thrombolysis time*, min, median (IQR) 38 (31–52) 51 (37–64) 0.03
Stroke onset to thrombolysis time*, min, median (IQR) 117 (89–175) 150 (106–210) 0.11
Hospital arrival to groin puncture time, min, median (IQR) 70 (53–90) 82 (67–101) 0.16
Stroke onset to groin puncture time, min, median (IQR) 186 (109–450) 210 (153–291) 0.79
mRS score 0–2 at discharge, n (%) 14 (32) 22 (45) 0.21

Numbers are n (%) or median (IQR) values as appropriate. Intergroup comparisons were performed using the Wilcoxon rank-sum test.

*

Only patients who received intravenous thrombolysis are included.

Only patients who received mechanical thrombectomy are included.

IQR, interquartile range; IVT, intravenous thrombolysis; MT, mechanical thrombectomy; NIHSS, National Institutes of Health Stroke Scale; mRS, modified Rankin scale.